AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
PRLB

Proto Labs Inc. Common stock (PRLB) fair value

Industrials · Metal Fabrication · NYSE · United States
$85.61+1.48%
Market cap $2.0BNext earnings 2026-10-29Updated Oct 24, 2026
Add earnings to calendarGoogle
Our verdict
Trades 151% above our fair value
Price
$85.61
Model fair valueConfidence: good
$34.17
Model range
$23.62 to $47.84
Fair value $34.17
Price $85.61
4 models fit Proto Labs Inc. Common stock and they partly agree: 2 of 4 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)Silver66
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionProto Labs Inc. Common stock (PRLB)
Fair value (4 models)
$34.17
ACCE price target
$90.00
Rating
Overvalued
Horizon
12 months
Fair value published on 24 Oct 2026, 16:06 CEST; previously $36.17 since 17 Oct 2026, 00:00 CEST.
ACCE price target published on 11 Oct 2026, 00:00 CEST.
Rating published on 24 Oct 2026, 16:06 CEST.
Price used: $85.61 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
150.5% above
-60.1% to fair value
ACCE score
64
out of 100
Analysts
80% buy
5 covering
P/E
67.9x
forward 35.9x
1-year return
+54.9%
Dividend yield
0.00%

Proto Labs Inc. Common stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Proto Labs runs on-demand manufacturing: customers upload CAD files and receive injection-molded plastic parts, CNC-machined metal parts, and 3D-printed prototypes and short-run production, quoted and often shipped within days. The moat is the digital quoting and automated production workflow, which lets it serve a long tail of low-volume customers that traditional job shops can't price efficiently. Revenue growth of 10.6% and a 45.4% gross margin show the model still compounds, though the 8.8% operating margin and 4.5% ROE leave little cushion and suggest the cost base is absorbing much of that gross profit. The stock trades at 32.3 times forward earnings against 69.4 times trailing, so the market is pricing a sharp earnings recovery that the next few quarters must confirm before the multiple compresses or holds. At a 2.1 billion dollar market cap with no index membership, it is a small, under-followed industrial where a margin inflection would matter more than another quarter of top-line growth.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 2 flagsAI-assisted·How I use AI
  • high
    Valuation stretched on model
    Price trades 150.5% above the model fair value of $34.17, and P/E of 68.0 against a forward P/E of 32.3 shows earnings growth is being priced in heavily.
  • moderate
    Thin returns on equity
    ROE of 4.5% and operating margin of 8.8% are modest for a stock at a P/S of 3.7, leaving little cushion if growth slows from the 10.6% revenue pace.

AI research notes

AI-assisted·How I use AIWritten Oct 19, 2026 · figures from 2026-10-16 · prices to Oct 23, 2026
Why it could do well
  • Revenue grew 10.6% year over year, well ahead of the company's 4.2% average annual pace over five years.
  • The company carries no debt, with a debt to equity ratio of 0.00, and generated $60M of free cash flow over the last twelve months.
Why it could disappoint
  • At $85.61, the stock trades 150.5% above the model fair value of $34.17, and four of five valuation models sit well below the price.
  • The trailing P/E of 68.0x sits far above the sector median forward P/E of 23.8x, and the forward P/E of 32.3x still carries a premium.
  • Return on invested capital is only 2.6% and net margin is 5.4%, and the latest quarter missed expected earnings per share by 5.1%.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Oct 29, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where PRLB's valuation models land
Price
$85.61
Model fair value
$34.17
Model range
$23.62 to $47.84
Fair value $34.17
Price $85.61
The price is above the whole model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish80% buy · 5 covering analysts
● Strong buy 3● Buy 1● Hold 1● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-0.0%
1 month
-3.9%
3 months
+9.4%
6 months
+32.5%
YTD
+69.2%
1 year
+54.9%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
24 Oct 2026, 16:06 CESTRatingOvervaluedfirst publication$85.61
24 Oct 2026, 16:06 CESTFair value$34.17$36.17$85.61
17 Oct 2026, 00:00 CESTFair value$36.17$36.85$87.41
12 Oct 2026, 00:00 CESTFair value$36.85$41.29$93.84
11 Oct 2026, 00:00 CESTACCE price target$90.00first publication$93.84
1 Oct 2026, 00:00 CESTFair value$41.29$41.71$95.46
28 Sept 2026, 00:00 CESTFair value$41.71$42.82$96.25
26 Sept 2026, 00:00 CESTFair value$42.82$41.61$92.97
20 Sept 2026, 00:00 CESTFair value$41.61$39.83$87.75
18 Sept 2026, 00:00 CESTFair value$39.83$38.93$83.24

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full PRLB page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth76Value25Quality59Momentum97Total64
Valuation
Trailing P/E
67.9x
Forward P/E
35.9x
PEG
0.64
P/B
3.08x
EV / Revenue
3.6x
Book value/sh
$28.92
Enterprise value
$2.0B
Profitability
ROE
4.5%
FCF yield
2.91%
ROIC
2.6%
Health and risk
Debt / equity
0.00
Dividend yield
0.00%
Beta
1.38

Price

+56.7% · 1Y

Ask anything about PRLB

Answered from Proto Labs Inc. Common stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 25% of peers
low 12.8x67.9xhigh 321.4x
ROEbetter than 50% of peers
low -21%4%high 16%
Div yieldbetter than 0% of peers
low 0.0%0.0%high 6.1%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
PRLB Proto Labs Inc. Common stock$85.61$34151% above67.9x4.5%5964
RHIM.L RHI Magnesita N.V.£25.35£3834% below12.8x9.9%3858
RYZ Ryerson Holding Corporation Common Stock$28.00----2.9%2164
WOR Worthington Enterprises Inc. Common Shares$63.65$4637% above19.2x16.2%6069
GPGI GPGI Inc. Class A Common Stock$11.34----20.6%3425
ESAB ESAB Corporation Common Stock$66.95$7814% below20.8x8.7%5646
TROAX.ST Troax Group AB (publ)kr 141.40kr 59141% above321.4x1.5%4248

Sector report card

Where PRLB ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Oct 9, 2026
    Protolabs Sets Conference Call to Discuss Third Quarter 2026 Financial Results
  • Business Wire•Sep 23, 2026
    Protolabs Accelerates the Future of Robotics with Rapid Manufacturing
  • Business Wire•Sep 4, 2026
    Protolabs Named to Business Insider’s America’s Most Innovative Businesses 2027 List
3 more press releases · full archive on Investor+.INVESTOR
40 filings
September 2026
Sep 25
Form 4Insider transactionPeriod 2026-09-24
View on SEC →
Sep 18
Form 4Insider transactionPeriod 2026-09-16
View on SEC →
August 2026
Aug 24
8-KCurrent reportPeriod 2026-08-24
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR